Literature DB >> 9232522

Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.

M M Nerurkar1, N F Ho, P S Burton, T J Vidmar, R T Borchardt.   

Abstract

The transport of the model peptide Acf(NMef)2NH2 across Caco-2 cell monolayers was studied in the apical (AP) to basolateral (BL) and the BL to AP direction in the presence of Polysorbate 80 or Cremophore EL in the AP compartment. Increasing surfactant concentrations resulted in increasing AP-->BL peptide permeability and decreasing BL-->AP permeability. In either direction, limiting permeabilities were achieved at concentrations less than the critical micellar concentrations (cmc's) of the surfactants, and remained constant at much higher concentrations. These plateau permeabilities were not equivalent in the two directions. This residual assymetry was abolished by increasing the peptide concentration. Altogether, the observations support the presence of at least two pumps in Caco-2 cells for this peptide, polarized in the BL-->AP direction. These experimental results were analyzed within the context of a quantitative biophysical model incorporating concurrent passive diffusion across the AP and BL membranes accompanied by surfactant-inhibitable active polarized efflux across the AP membrane. The model was also used to locate the additional transport activity at the BL membrane as an uptake pump. Under conditions of complete inhibition, the intrinsic passive diffusional permeability of Acf(NMef)2NH2 was found to be 13 x 10(-6) cm/s, essentially identical with results reported earlier with this peptide utilizing verapamil as an inhibitor. With respect to the mechanism of surfactant inhibition of the apical efflux transport, the monomeric species was found to be responsible with no contribution from micelles. Modeling the mode of inhibition as a noncompetitive Michaelis-Menten process gave identical Kis of 0.5 microM for the two surfactants. Finally, increase of either surfactant beyond 750 microM resulted in a decrease of peptide permeability in the AP-->BL direction. This was attributed to weak association of the peptide with micelles in the AP compartment, which effectively decreased the thermodynamic activity of the peptide at surfactant concentrations greater than 20 times their cmc. Both the experimental approach and accompanying theoretical model demonstrated in this work will allow for further characterization of the inhibitory potencies of surfactants for the nonpassive efflux pathway in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232522     DOI: 10.1021/js960483y

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

Review 1.  The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.

Authors:  Arik Dahan; Jonathan M Miller
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

2.  Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Authors:  Xiaobin Zhang; Daria Y Alakhova; Elena V Batrakova; Shu Li; Zhihui Yang; Yili Li; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-02       Impact factor: 4.147

Review 3.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

4.  Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

Authors:  L Yu; A Bridgers; J Polli; A Vickers; S Long; A Roy; R Winnike; M Coffin
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

5.  PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.

Authors:  Daisuke Kozutsumi; Masako Tsunematsu; Taketo Yamaji; Rika Murakami; Minehiko Yokoyama; Kohsuke Kino
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

6.  Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.

Authors:  Viral F Patel; Natavarlal M Patel
Journal:  AAPS PharmSciTech       Date:  2006-02-24       Impact factor: 3.246

7.  Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.

Authors:  E V Batrakova; H Y Han; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

8.  Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.

Authors:  Jason Zastre; John Jackson; Helen Burt
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

9.  In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.

Authors:  A Crowe; M Lemaire
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

10.  Method to screen substrates of apical sodium-dependent bile acid transporter.

Authors:  Rana Rais; Pablo M Gonzalez; Xiaowan Zheng; Stephen A Wring; James E Polli
Journal:  AAPS J       Date:  2008-12-16       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.